相似文献
1
[Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
Arq Bras Cardiol. 1985 Jul;45(1):31-6.
2
Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
J Perinat Med. 2004;32(4):368-74. doi: 10.1515/JPM.2004.069.
3
[Prostaglandin treatment of ductus-dependent congenital heart defects].
Lakartidningen. 1984 Oct 3;81(40):3619-22.
4
5
Prostaglandins and the management of congenital heart disease.
Am Fam Physician. 1982 Dec;26(6):127-32.
6
[Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
Ugeskr Laeger. 1979 Jul 9;141(28):1915-6.
7
Prostaglandin E1 treatment in ductus dependent congenital cardiac malformation. A review of the treatment of 34 neonates.
Dan Med Bull. 1988 Feb;35(1):81-4.
8
Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
J Am Coll Cardiol. 1983 Feb;1(2 Pt 1):471-5. doi: 10.1016/s0735-1097(83)80075-8.
9
Nursing care of the neonate receiving prostaglandin E1 therapy.
Neonatal Netw. 1993 Jun;12(4):17-22.
10
[Skeletal side effects of treatment with prostaglandin E1].
Rofo. 1984 Oct;141(4):427-30. doi: 10.1055/s-2008-1053163.
Zotero 插件